Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Concurrent dual contrast for cellular magnetic resonance imaging using gadolinium oxide and iron oxide nanoparticles.

Loai Y, Ganesh T, Cheng HL.

Int J Mol Imaging. 2012;2012:230942. doi: 10.1155/2012/230942.

2.
3.

Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.

Yang H, Zhuang Y, Sun Y, Dai A, Shi X, Wu D, Li F, Hu H, Yang S.

Biomaterials. 2011 Jul;32(20):4584-93. doi: 10.1016/j.biomaterials.2011.03.018.

PMID:
21458063
4.

Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury.

Shen J, Zhong XM, Duan XH, Cheng LN, Hong GB, Bi XB, Liu Y.

Acad Radiol. 2009 Sep;16(9):1142-54. doi: 10.1016/j.acra.2009.03.016.

PMID:
19660710
5.

Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.

Faucher L, Tremblay M, Lagueux J, Gossuin Y, Fortin MA.

ACS Appl Mater Interfaces. 2012 Sep 26;4(9):4506-15.

PMID:
22834680
6.

Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking.

Hsiao JK, Tsai CP, Chung TH, Hung Y, Yao M, Liu HM, Mou CY, Yang CS, Chen YC, Huang DM.

Small. 2008 Sep;4(9):1445-52. doi: 10.1002/smll.200701316.

PMID:
18680095
7.
8.

Iron oxide based MR contrast agents: from chemistry to cell labeling.

Laurent S, Boutry S, Mahieu I, Vander Elst L, Muller RN.

Curr Med Chem. 2009;16(35):4712-27. Review.

PMID:
19903138
9.

Cationic Gd-DTPA liposomes for highly efficient labeling of mesenchymal stem cells and cell tracking with MRI.

Guenoun J, Koning GA, Doeswijk G, Bosman L, Wielopolski PA, Krestin GP, Bernsen MR.

Cell Transplant. 2012;21(1):191-205. doi: 10.3727/096368911X593118.

PMID:
21929868
10.
11.

Iron oxide-loaded liposomes for MR imaging.

Meincke M, Schlorf T, Kossel E, Jansen O, Glueer CC, Mentlein R.

Front Biosci. 2008 May 1;13:4002-8.

PMID:
18508493
12.

Dual contrast magnetic resonance imaging tracking of iron-labeled cells in vivo.

Wu S, Zhang L, Zhong J, Zhang Z.

Cytotherapy. 2010 Nov;12(7):859-69. doi: 10.3109/14653241003587652. Review.

PMID:
20184501
13.

Cellular level loading and heating of superparamagnetic iron oxide nanoparticles.

Kalambur VS, Longmire EK, Bischof JC.

Langmuir. 2007 Nov 20;23(24):12329-36.

PMID:
17960940
15.
16.

Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging.

Anderson SA, Lee KK, Frank JA.

Invest Radiol. 2006 Mar;41(3):332-8.

PMID:
16481917
17.

Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.

Chen Z, Yu D, Liu C, Yang X, Zhang N, Ma C, Song J, Lu Z.

J Drug Target. 2011 Sep;19(8):657-65. doi: 10.3109/1061186X.2010.531727.

PMID:
21091273
18.

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.

Hu F, Jia Q, Li Y, Gao M.

Nanotechnology. 2011 Jun 17;22(24):245604. doi: 10.1088/0957-4484/22/24/245604.

PMID:
21508500
19.

Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.

Kim BH, Lee N, Kim H, An K, Park YI, Choi Y, Shin K, Lee Y, Kwon SG, Na HB, Park JG, Ahn TY, Kim YW, Moon WK, Choi SH, Hyeon T.

J Am Chem Soc. 2011 Aug 17;133(32):12624-31. doi: 10.1021/ja203340u.

PMID:
21744804
20.

The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells.

Kim HS, Oh SY, Joo HJ, Son KR, Song IC, Moon WK.

NMR Biomed. 2010 Jun;23(5):514-22. doi: 10.1002/nbm.1487.

PMID:
20175151

Supplemental Content

Support Center